Healthlead PCL (BKK:HL) Debt-to-Asset : 0.18 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Healthlead PCL Debt-to-Asset?

Healthlead PCL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ฿28 Mil. Healthlead PCL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ฿227 Mil. Healthlead PCL's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ฿1,432 Mil. Healthlead PCL's debt to asset for the quarter that ended in Mar. 2024 was 0.18.

Healthlead PCL Debt-to-Asset Historical Data

The historical data trend for Healthlead PCL's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthlead PCL Debt-to-Asset Chart

Healthlead PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

0.19

0.34

0.11

0.13

0.16

Healthlead PCL Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial											0.14	0.15	0.15	0.16	0.18

Competitive Comparison of Healthlead PCL's Debt-to-Asset

For the Medical Distribution subindustry, Healthlead PCL's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healthlead PCL's Debt-to-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Healthlead PCL's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Healthlead PCL's Debt-to-Asset falls into.

Healthlead PCL Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Healthlead PCL's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(25.354	+	198.947)	/	1382.345
	=	0.16

Healthlead PCL's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(28.399	+	226.734)	/	1432.077
	=	0.18

Healthlead PCL (BKK:HL) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Healthlead PCL Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Healthlead PCL's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Healthlead PCL (BKK:HL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Healthlead PCL (BKK:HL) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140

Website

https://www.healthleadgroup.com

Healthlead PCL is engaged in the business of healthcare-related and medical products. It operates in the pharmacy business, distribution of medical supplies, cosmeceuticals, and dietary supplements. medical equipment and various health products. as well as in business regarding invention business, developing, importing, and distributing innovative healthcare products.